In a high-level meeting on COVID-19 policies, organised by EMA under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA), international regulators from around the world discussed strategic issues and regulatory approaches to ensure a coordinated response to the pandemic. They stressed the need for alignment on pre- and post-authorisation regulatory requirements to facilitate the rapid development, evaluation and availability of medicines for the treatment and prevention of coronavirus disease.
source https://www.pharmatutor.org/pharma-news/2020/global-regulators-work-towards-alignment-on-policy-approaches-and-regulatory-flexibility-during-covid-19
No comments:
Post a Comment